Forecast

There is no analyst data available for this company.

News Go to news feed

Tecan falls after H1 figures and cautious outlook

Tecan reported H1 2026 revenue of 427.5 million CHF and adjusted EBITDA of 64.5 million CHF (margin 15.1%), but showed weaker reported revenue, a sharply reduced operating cash flow of 17 million CHF and margin pressure. The share fell about 9% to $183.90 as investors reacted particularly to the decline in gross margins and continued transformation spending. Management kept the full-year guidance unchanged and expects low single-digit revenue growth and an adjusted EBITDA margin of 15.5–16.5%, now targeting the top end of the range. » More on de.investing.com
Tecan announces conference call to present half-year results on 11 August

Tecan will explain the financial results for the first half of 2026 on Tuesday, 11 August 2026 at 09:00 CET in an English-language conference call; the press release will be published the same morning at 07:00 CET. The presentation will be available via telephone dial-in or webcast with synchronized slides; dial-in details will be published in advance. The full half-year report 2026 will be available from 11 August in the Investor Relations section of the company website. » More on finanzen.net
Tecan (N) approves dividend of CHF 3.00 per share for 2025

At the annual general meeting on 15 April 2026, Tecan (N) approved a dividend of CHF 3.00 per share for 2025, totaling CHF 38.03 million. The dividend yield for 2025 is 2.33% based on the closing price on the AGM date of CHF 141.40; the stock is trading ex-dividend as of today. Over three years the share price is down around 64.98%. Analysts at FactSet expect the dividend to rise to CHF 3.40 by 2029. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Tecan N has already paid 3,27€ in dividends. The last payout was in April.

Financials

In the last quarter, Tecan N had revenue of 463.16m€ and net profit of 13.29m€

(EUR)	Jun 2026	YoY
Revenue	+463.16m	-
Gross profit	+157.02m	-
Net profit	+13.29m	-
EBITDA	+50.64m	-

Fundamentals

Metric	Value
Market capitalization	+2.62b€
Number of shares	12.66m
52-week high/low	+215,58€ - +118,03€
Dividend yield	+1,64%
Dividends TTM	+3,27€
Beta	1,08
P/E ratio	−21,20
PEG ratio	+0,08
P/B ratio	+2,15
P/S ratio	+2,82

Company profile

Die Tecan Group AG bietet Laborinstrumente und -lösungen für Pharma- und Biotechnologieunternehmen, universitäre Forschungsabteilungen sowie forensische und diagnostische Labors an. Das Unternehmen ist in den Segmenten Life Sciences Business und Partnering Business tätig. Das Unternehmen bietet Liquid Handling und Automation, Mikroplatten-Reader und Washers, Verbrauchsmaterialien, NGS-Reagenzien, Immunoassays und Mikrokörper sowie Software; Tecan Laberwax, eine Automationslösung; Resolvex, eine intelligente Probenvorbereitungslösung für den Einsatz in der Genomik, der synthetischen Biologie, der Arzneimittelforschung, der analytischen Chemie, der Zellbiologie, der Proteinforschung, in angewandten Märkten und ELISA-Lösungen. Darüber hinaus entwickelt und produziert das Unternehmen Laborgeräte mit wesentlichen Komponenten wie Präzisionspumpen, Ventilen, Roboterarmen und Entwicklersoftware für die Life-Science-Forschung, die Diagnostik und verschiedene andere Industriezweige; Synergence, eine plattformbasierte Automatisierungslösung, sowie die Instrumente Freedom EVO und Fluent. Das Unternehmen ist in der Schweiz und anderen europäischen Ländern, in Nordamerika, Asien und international tätig. Die Tecan Group AG wurde 1980 gegründet und hat ihren Hauptsitz in Männedorf, Schweiz.

Name	Tecan N
CEO	Monica Manotas
Headquarters	Männedorf, zh Switzerland
Website	tecan.com
Sector	Health Care
Industry	Life Sciences Tools & Services
IPO	04/10/1995
Employees	3.000